Latest Earnings Results: Q3 '26
Estimated EPS
$5.54
Reported EPS
$5.71
Surprise
+3.04%
Estimated Rev
$214.82M
Reported Rev
$217.6M
Surprise
+1.3%
• Reported GAAP EPS of $5.71 down -26.42% YoY • Reported revenue of $217.61M down -18.74% YoY
Bullish Takeaway
Nutex Health reported higher Hospital Division visits, prevailed in over 80% of arbitration award determinations, and cited a robust de novo pipeline with two new hospitals expected to open in Q4.
Bearish Takeaway
Nutex Health reported lower Q3 revenue and attributable earnings year over year, while identifying No Surprises Act uncertainty and insurer litigation against its arbitration provider as risks.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $5.95 | -- | -- | N/A |
Q3 '26 | $5.54 | $5.71 | 3.04% | BEAT |
Q2 '26 | $4.95 | $9.38 | 89.34% | BEAT |
Q1 '26 | $3.99 | $6.52 | 63.27% | BEAT |
Q4 '25 | $5.56 | $1.69 | -69.53% | MISSED |